(2019). A multicenter study to evaluate ceftaroline breakpoints: Performance in an area with high prevalence of methicillin- resistant Staphylococcus aureus sequence type 5 lineage.
Chicago Style (17th ed.) CitationA Multicenter Study to Evaluate Ceftaroline Breakpoints: Performance in an Area with High Prevalence of Methicillin- Resistant Staphylococcus Aureus Sequence Type 5 Lineage. 2019.
MLA (8th ed.) CitationA Multicenter Study to Evaluate Ceftaroline Breakpoints: Performance in an Area with High Prevalence of Methicillin- Resistant Staphylococcus Aureus Sequence Type 5 Lineage. 2019.
Warning: These citations may not always be 100% accurate.